Page last updated: 2024-11-02

phentermine and Dyslipidemia

phentermine has been researched along with Dyslipidemia in 2 studies

Phentermine: A central nervous system stimulant and sympathomimetic with actions and uses similar to those of DEXTROAMPHETAMINE. It has been used most frequently in the treatment of obesity.

Research Excerpts

ExcerptRelevanceReference
"To evaluate the efficacy and safety of a newly developed formulation of phentermine diffuse-controlled release (DCR) in patients with obesity."9.14Randomized controlled trial to investigate the effects of a newly developed formulation of phentermine diffuse-controlled release for obesity. ( Kang, JG; Kang, JH; Park, CY; Park, SW; Park, YW, 2010)
"To evaluate the efficacy and safety of a newly developed formulation of phentermine diffuse-controlled release (DCR) in patients with obesity."5.14Randomized controlled trial to investigate the effects of a newly developed formulation of phentermine diffuse-controlled release for obesity. ( Kang, JG; Kang, JH; Park, CY; Park, SW; Park, YW, 2010)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kang, JG1
Park, CY1
Kang, JH1
Park, YW1
Park, SW1
Hendricks, EJ1
Rothman, RB1

Trials

1 trial available for phentermine and Dyslipidemia

ArticleYear
Randomized controlled trial to investigate the effects of a newly developed formulation of phentermine diffuse-controlled release for obesity.
    Diabetes, obesity & metabolism, 2010, Volume: 12, Issue:10

    Topics: Adult; Appetite Depressants; Delayed-Action Preparations; Diabetic Angiopathies; Double-Blind Method

2010

Other Studies

1 other study available for phentermine and Dyslipidemia

ArticleYear
Phentermine therapy for obesity does not elevate blood pressure.
    Diabetes, obesity & metabolism, 2011, Volume: 13, Issue:10

    Topics: Appetite Depressants; Delayed-Action Preparations; Diabetic Angiopathies; Dyslipidemias; Female; Hum

2011